Maiya Health and Peking Union Medical College Hospital Forge Strategic Collaboration to Advance Integrated Diagnosis, Treatment, and Wellness Solutions for High-Quality Hospital Development

In 2008, Zhu Chengbo, founder and CEO of Maiya Health, was first introduced to medical nutrition therapy and functional medicine by chance. With a longstanding “entrepreneurial dream,” Zhu keenly identified the market opportunity.

Zhu Chengbo recalled, “After my initial exposure, I recognized the product value and market demand arising from the integration of lifestyle medicine with clinical practice. This synergy not only aligns with clinical needs and promotes high-quality development of hospital specialties, but also generates social and commercial value, facilitating the redistribution of healthcare service resources.”

Opportunities lay ahead, but Zhu Chengbo did not rush to take action. Instead, he focused on “strengthening his core competencies.” Between 2008 and 2015, he dedicated himself to the application of medical nutrition therapy for metabolic syndrome and the use of functional medicine assessment and intervention techniques, building a solid foundation in quality control, standardization, quantification, and process optimization for technologies and services supporting lifelong health management.

In 2015, the surge of entrepreneurship driven by the “Internet + Smart Healthcare” trend prompted Zhu Chengbo to establish Maiya Health. The company aims to build a service ecosystem for full-lifecycle health management covering pre-diagnosis, during-diagnosis, and post-diagnosis stages, leveraging medical data and digital therapeutics as its core capabilities to establish a lean operational model with sustainable profitability.

Eight Years On, Maiya HealthFromCampFocusing on specialized care, maternal and child health, and chronic disease management, the company has established a business layout encompassing smart healthcare, smart services, and smart retail, with operations spanning Beijing, Liaoning, Hunan, Fujian, Shandong, Guangzhou, Gansu, Inner Mongolia, Anhui, and other regions.

In 2022, the case study on the construction and implementation of the “Smart Maternal Health Service System,” jointly submitted by Maiya Health and Peking Union Medical College Hospital, was successfully selected as one of the Typical Cases of Modern Hospital Management in China for 2022 at the 2022 Annual Selection Conference for Typical Cases of Modern Hospital Management in China.

Zhu Chengbo, Founder and CEO of Maiya Health, has 16 consecutive years of entrepreneurial experience in the healthcare sector, having developed a clear industrial logic and deep industry understanding of health services, smart hospital development, and lean hospital operations.

Zhu Chengbo is an advocate of “integrated specialized diagnosis, treatment, and healthcare services.” He pioneered the integrated operational model of “medical data, health services, and health selection” in China. He also serves as the Chief Nutrition Expert for Beijing’s “Preventive Treatment of Disease” Initiative and President of the Liaoning Provincial Society for Medical Nutrition Prevention and Treatment of Diabetes.

Maiya Health is headquartered in Beijing, with a branch office in Shenyang and operational teams extending to Guangdong, Fujian, and other regions. Both Beijing and Shenyang, the central city of Northeast China, boast substantial accumulations of medical resources, with their numbers of Grade A tertiary hospitals ranking among the highest nationwide. “This geographic distribution of our team enables Maiya Health to better reach and more rapidly respond to the service needs of hospitals,” said Zhu Chengbo.

The core management positions at Maiya Health are also held by seasoned professionals with extensive experience in operational services. Their years of expertise in implementing health management and services have laid a soft-power foundation for Maiya Health’s development, characterized by business-driven growth supported by informational capabilities.

Over the past eight years, Maiya Health has remained dedicated to the field of maternal and child health, offering smart informatics products and healthcare services for women and children. By achieving interoperability with hospital Hospital Information Systems (HIS), it provides an integrated solution of “obstetrics software + health services,” covering the entire spectrum of care both within and outside hospital settings.

It is worth noting that,Maiya Health has been exploring digital therapeutics since 2018 and has achieved significant results., supported by extensive real-world evidence, it demonstrates the efficacy of digital therapeutics in improving patient symptoms from an evidence-based medicine perspective. Maiya Health has conducted in-depth research in specialized fields such as maternal and child health and chronic diseases, and has jointly carried out multiple research projects on digital therapeutics with Shengjing Hospital of China Medical University, Peking Union Medical College Hospital, Guangzhou Baiyun District Maternal and Child Health Hospital, and Sanofi.

By leveraging its proprietary digital technologies, Maiya Health aggregates patients’ in-hospital clinical data with out-of-hospital lifestyle information and risk assessment data into comprehensive digital health records. Through evidence-based standard pathways for digital therapeutics, it identifies pathogenic factors and translates clinical treatment orders into actionable daily health prescriptions. The platform collects and integrates patient adherence data, providing feedback to physicians in the form of periodic reports accompanied by professional health management interpretations. This approach supplies real-world data support for both physicians and patients to address underlying causes through lifestyle modifications, thereby substantially enhancing health management outcomes for participating patients and improving adverse positive clinical indicators.

Maiya Health has also accumulated real-world research data on disease-specific digital therapeutics, demonstrating from an evidence-based medicine perspective the efficacy of digital therapeutics in improving patients' health outcomes.

From the development trajectory of Maiya Health, it is evident that the company has been actively participating in clinical research activities at various levels across China. Zhu Chengbo stated that involvement in research projects serves to validate the real-world effectiveness of their health management model from an evidence-based scientific perspective. This enables Maiya Health to build capabilities in multi-disciplinary structured data collection, standardized governance, and intelligent analysis within medical services, thereby forming a distinctive service capability that combines informatization with health management to support real-world research. “Throughout the project’s progression, we have also gained significant recognition from leading experts and research-oriented medical institutions regarding our health management service capabilities.”

Maiya Health’s self-developed integrated clinical research platform facilitates data collection for multi-center clinical study cohorts. Through standardized data governance, it establishes disease-specific research data standards aligned with clinical practice, enabling participating clinicians to access high-quality databases of enrolled patients during routine diagnosis and treatment.

Meanwhile, leveraging the characteristics of its operational services, Maiya Health involves health managers in the joint design of research projects with experts. By integrating health services into these research initiatives, it empowers both physicians and patients, enhances patient compliance, and ensures efficient, high-quality post-discharge follow-up and management. This approach facilitates the continuous collection of out-of-hospital patient data, thereby establishing a closed-loop data ecosystem that connects in-hospital and out-of-hospital research.

Maiya Health provides integrated informatics and service-based solutions for scientific research projects. It has participated in the clinical cohort study led by Peking Union Medical College Hospital titled “Clinical Cohort Study on the Impact of Periconceptional Vitamin D Nutritional Status Management on Pregnancy Outcomes,” as well as the project on “Gestational Weight Gain in Gestational Diabetes Mellitus (GDM) Across China.” Additionally, Maiya Health collaborated with Shengjing Hospital of China Medical University to conduct the clinical study titled “Clinical Effectiveness of Medical Nutrition Therapy Combined with Insulin or Insulin Plus Metformin in the Treatment of Gestational Diabetes Mellitus.”

Take the “Clinical Cohort Study on the Management of Periconceptional Vitamin D Nutritional Status to Improve Pregnancy Outcomes,” completed in collaboration with Peking Union Medical College Hospital in 2019, as an example. Leveraging the Maiyan Scientific Research Cloud Platform, the project rapidly expanded to cover 70 satellite centers, with an anticipated sample size of 20,000 cases. It achieved out-of-hospital data collection for health management programs based on real-world studies and established an evidence-based health management intervention model.

Since the day he decided to start his business, Zhu Chengbo has been contemplating how to enable the company to both “move fast” and “go far.” After in-depth market research, Maiya Health established its business system in the field of smart maternal and child health, encompassing in-hospital diagnosis and treatment, out-of-hospital services, and curated health products. This system covers three distinct yet synergistic operational lines—informational software products, doctor-patient services and products, and curated goods—each capable of independent development while also supporting integrated operations.

Zhu Chengbo concluded,Maiya Health excels at entering the market through specialized disciplines, building a product matrix that includes specialty-specific information systems, digital therapeutics for specific diseases, and refined operational service capabilities. It has established strong capabilities in identifying customer needs and delivering solutions for advantageous disease categories, successfully validated its commercialization pathway, and is now planning to rapidly replicate this model across other medical departments.。

Although Malt Health experienced a difficult period due to the impact of the pandemic, “no winter is insurmountable, and no spring fails to arrive.” Moving forward, Malt Health will further strengthen its research capabilities in the field of digital therapeutics, while enhancing its specialized healthcare service capabilities and operational capacities for channels and medical institutions. The company aims to provide high-quality, integrated diagnostic, treatment, and healthcare solutions to support the development of more specialized medical consortia.